Halozyme Therapeutics (HALO) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

HALO is expected to report earnings to rise 9.89% to $1.00 per share on November 04

Halozyme Therapeutics HALO Stock Earnings Reports

Q3'24

Est.

$1.00

Q2'24

Beat

by $0.15

Q1'24

Beat

by $0.10

Q4'23

Beat

by $0.02

Q3'23

Beat

by $0.05

The last earnings report on August 06 showed earnings per share of 91 cents, beating the estimate of 75 cents. With 908.26K shares outstanding, the current market capitalization sits at 7.50B.

View a ticker or compare two or three

Compare

HALO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For HALO
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for HALO (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

12390 El Camino Real

Phone

+1 858 794-8889

Employees

373

Web

https://www.halozyme.com